Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Gains from Investment Securities (2023 - 2025)

Medinotec filings provide 3 years of Gains from Investment Securities readings, the most recent being $135441.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 889.78% to $135441.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $1.3 million, a 324.9% increase, with the full-year FY2025 number at $737389.0, up 427.79% from a year prior.
  • Gains from Investment Securities hit $135441.0 in Q4 2025 for Medinotec, down from $193942.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $697550.0 in Q1 2025 to a low of -$489746.0 in Q1 2024.
  • Median Gains from Investment Securities over the past 3 years was $135441.0 (2025), compared with a mean of $149527.7.
  • Biggest five-year swings in Gains from Investment Securities: crashed 97.83% in 2024 and later soared 1368.48% in 2025.
  • Medinotec's Gains from Investment Securities stood at $629458.0 in 2023, then crashed by 97.83% to $13684.0 in 2024, then surged by 889.78% to $135441.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $135441.0 (Q4 2025), $193942.0 (Q3 2025), and $262846.0 (Q2 2025) per Business Quant data.